Guankui Wang

2.1k total citations · 1 hit paper
38 papers, 1.7k citations indexed

About

Guankui Wang is a scholar working on Biomaterials, Immunology and Molecular Biology. According to data from OpenAlex, Guankui Wang has authored 38 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Biomaterials, 15 papers in Immunology and 13 papers in Molecular Biology. Recurrent topics in Guankui Wang's work include Nanoparticle-Based Drug Delivery (18 papers), Complement system in diseases (13 papers) and RNA Interference and Gene Delivery (9 papers). Guankui Wang is often cited by papers focused on Nanoparticle-Based Drug Delivery (18 papers), Complement system in diseases (13 papers) and RNA Interference and Gene Delivery (9 papers). Guankui Wang collaborates with scholars based in United States, United Kingdom and China. Guankui Wang's co-authors include Dmitri Simberg, S. Moein Moghimi, Nirmal K. Banda, V. Michael Holers, Linping Wu, James I. Griffin, Rodney A. Hill, Robert I. Scheinman, Donald S. Backos and Fangfang Chen and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Guankui Wang

36 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo

2016 455 citations Fangfang Chen, Guankui Wang et al. Nature Nanotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guankui Wang United States	21	812	577	546	373	293	38	1.7k
Kyrylo Tron Germany	18	489 0.6×	491 0.9×	341 0.6×	373 1.0×	449 1.5×	27	1.7k
Tobias Pfaller Austria	9	726 0.9×	534 0.9×	460 0.8×	287 0.8×	691 2.4×	10	1.9k
Douglas R. Vogus United States	14	659 0.8×	491 0.9×	549 1.0×	113 0.3×	194 0.7×	17	1.4k
Jung Seok Lee United States	21	797 1.0×	718 1.2×	574 1.1×	142 0.4×	288 1.0×	41	2.0k
Blaine J. Zern United States	16	580 0.7×	487 0.8×	463 0.8×	130 0.3×	156 0.5×	19	1.4k
Svenja Winzen Germany	13	1.0k 1.3×	661 1.1×	594 1.1×	104 0.3×	328 1.1×	17	1.8k
Randall Toy United States	16	757 0.9×	429 0.7×	779 1.4×	216 0.6×	310 1.1×	22	1.6k
Todd D. Giorgio United States	30	764 0.9×	1.6k 2.7×	868 1.6×	484 1.3×	253 0.9×	93	3.4k
Ilia Fishbein United States	24	818 1.0×	866 1.5×	519 1.0×	175 0.5×	207 0.7×	61	2.4k
Evan A. Scott United States	30	770 0.9×	813 1.4×	734 1.3×	605 1.6×	405 1.4×	85	2.6k

Countries citing papers authored by Guankui Wang

Since Specialization

Citations

This map shows the geographic impact of Guankui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guankui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guankui Wang more than expected).

Fields of papers citing papers by Guankui Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guankui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guankui Wang. The network helps show where Guankui Wang may publish in the future.

Co-authorship network of co-authors of Guankui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Guankui Wang. A scholar is included among the top collaborators of Guankui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guankui Wang. Guankui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vázquez‐Torres, Andrés, Guankui Wang, Dmitri Simberg, et al.. (2025). Nanogels conjugated with cell-penetrating peptide as drug delivery vehicle for treating urinary tract infections. Nanomedicine Nanotechnology Biology and Medicine. 65. 102812–102812.

Li, Yue, Hanmant Gaikwad, Guankui Wang, et al.. (2023). Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins. Nature Nanotechnology. 19(2). 246–254. 26 indexed citations

Gaikwad, Hanmant, Yue Li, Guankui Wang, et al.. (2022). Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on “Pseudovirus-like” Nanoparticles. ACS Nano. 16(6). 8704–8715. 8 indexed citations

Balyasnikova, Irina V., Μαρκέλλα Ζαννίκου, Guankui Wang, et al.. (2022). Indocarbocyanine nanoparticles extravasate and distribute better than liposomes in brain tumors. Journal of Controlled Release. 349. 413–424. 9 indexed citations

Wang, Guankui, Hanmant Gaikwad, Mary K. McCarthy, et al.. (2021). Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro. SHILAP Revista de lepidopterología. 4(1). 724–737. 18 indexed citations

Wang, Guankui, Hanmant Gaikwad, Mary K. McCarthy, et al.. (2021). Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro. 1 indexed citations

Zhang, Wei, Hanmant Gaikwad, Ernest Groman, et al.. (2021). Highly aminated iron oxide nanoworms for simultaneous manufacturing and labeling of chimeric antigen receptor T cells. Journal of Magnetism and Magnetic Materials. 541. 168480–168480. 5 indexed citations

Yang, Chunyan, Fangfang Chen, Ping Ren, et al.. (2020). Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticles. Journal of Controlled Release. 326. 324–334. 5 indexed citations

Gaikwad, Hanmant, Yue Li, Ernest Groman, et al.. (2020). Complement Inhibitors Block Complement C3 Opsonization and Improve Targeting Selectivity of Nanoparticles in Blood. Bioconjugate Chemistry. 31(7). 1844–1856. 11 indexed citations

10.

Banda, Nirmal K., Stephen Tomlinson, Robert I. Scheinman, et al.. (2020). C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice. Frontiers in Immunology. 11. 575154–575154. 7 indexed citations

11.

Wang, Guankui, Natalie J. Serkova, Ernest Groman, Robert I. Scheinman, & Dmitri Simberg. (2019). Feraheme (Ferumoxytol) Is Recognized by Proinflammatory and Anti-inflammatory Macrophages via Scavenger Receptor Type AI/II. Molecular Pharmaceutics. 16(10). 4274–4281. 23 indexed citations

12.

Vu, Vivian, Fangfang Chen, Guankui Wang, et al.. (2018). Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles. Nature Nanotechnology. 14(3). 260–268. 243 indexed citations

13.

Griffin, James I., Guankui Wang, Vivian Vu, et al.. (2017). Revealing Dynamics of Accumulation of Systemically Injected Liposomes in the Skin by Intravital Microscopy. ACS Nano. 11(11). 11584–11593. 29 indexed citations

14.

Wang, Guankui, James I. Griffin, Swetha Inturi, et al.. (2017). In Vitro and In Vivo Differences in Murine Third Complement Component (C3) Opsonization and Macrophage/Leukocyte Responses to Antibody-Functionalized Iron Oxide Nanoworms. Frontiers in Immunology. 8. 151–151. 45 indexed citations

15.

Wang, Guankui, Guixin Shi, Michael J. Benchimol, et al.. (2017). Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles. Colloids and Surfaces B Biointerfaces. 161. 200–209. 14 indexed citations

16.

Chen, Fangfang, Guankui Wang, James I. Griffin, et al.. (2016). Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. Nature Nanotechnology. 12(4). 387–393. 455 indexed citations breakdown →

17.

Wang, Guankui, Intak Jeon, Boo Hyun An, et al.. (2016). Radio frequency-mediated local thermotherapy for destruction of pancreatic tumors using Ni–Au core–shell nanowires. Nanotechnology. 28(3). 03LT01–03LT01. 61 indexed citations

18.

Banda, Nirmal K., Gaurav Mehta, Ying S. Chao, et al.. (2014). Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum. Particle and Fibre Toxicology. 11(1). 64–64. 78 indexed citations

19.

Wang, Guankui, et al.. (2012). KDEL peptide gold nanoconstructs: promising nanoplatforms for drug delivery. Nanomedicine Nanotechnology Biology and Medicine. 9(3). 366–374. 53 indexed citations

20.

Wang, Guankui, et al.. (2011). Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer. mAbs. 3(5). 467–478. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact